June 2009
Carr Auditorium, 12:00 - 1:00 pm
June 2
|
Ventricular Function Matters
Ann Bolger, MD
William Watt Kerr Professor of Clinical Medicine
Division of Cardiology, SFGH, UCSF
|
June 9
|
Achieving Universal Access to Health Care: Healthy San Francisco
Mitch Katz, MD MPH
Director, SF Dept of Public Health;
Clinical professor Medicine & Epidemiology, UCSF
- Review research on the negative health consequences of not having insurance.
- Identify reasons why prior attempts at providing universal health insurance in the United States have failed.
- Describe features that facilitate achievement of universal health coverage on the local level.
|
June 16
|
Debate: Should Physician Aid in Dying be Legalized?
Doug White*, MD
Robert Brody**, MD
Joseph Dunn***, MD
* Assistant Professor University of California, San Francisco
Division of Pulmonary and Critical Care Medicine
UCSF Director, Clinical Ethics Core UCSF
** Clinical Professor, Dept of Medicine, and Dept of Family and Community Medicine
*** Joseph Dunn, Esq., Chief Executive Officer, California Medical Association
- to understand the arguments for and against legalizing physician aid in
dying as a public policy
|
June 23
|
Update on Osteoporosis
Steve Harris, MD
Clinical professor of Medicine, UCSF Division of Endocrinology and Metabolism
- The relationships among bone density, age, previous fracture and future
- The effects of calcium, vitamin D, estrogen, calcitonin, raloxifene, alendronate, ibandronate, zoledronic acid and PTH upon bone
- The advantages and disadvantages of different treatment agents
- The advantages and disadvantages of a Òdrug holidayÓÑstopping treatment
of years
- The new treatment agents likely to be available within the next couple of
Upon completion of this program, participants will understand the rational
pharmacological agents for the prevention and treatment of osteoporosis.
|
June 26
|
PRIMARY CARE: Sustainable Food
Sarah Janssen, MD
|
June 30
|
Heroin in Brown, Black and White: Trends and Medical Consequences
Dan Ciccarone MD, MPH
Co-Director, UCSF Foundations of Patient Care Course
Associate Professor of Clinical Family and Community Medicine,
Step 2 Family and Community Medicine University of California,
San Francisco School of Medicine; Associate Professor, Anthropology, History and
Social Medicine University of California, San Francisco School of Medicine
- Discuss the distribution of different types and qualities of heroin throughout the United States
- Discuss market trends in heroin quality, including price and purity
- Discuss the medical consequences of use of different types of heroin, as well as the public health implications of increasing heroin quality over time
|
The speaker(s) declare that neither they nor any immediate family have
financial or other arrangements with the manufacturers of any
pharmaceutical products or medical devices discussed in this CME
activity. The speaker(s) indicate that they do not intend to discuss
investigational or off label use of pharmaceutical products or medical
devices.
UCSF is accredited b the Accreditation Council for Continuing Medical
Education (ACCME) to provide continuing medical education for
physicians and allied health care professionals. -- CME credit is one
hour.
No commercial support was received for this CME activity.
|